Literature DB >> 17157070

Prevalence of Toll-like receptor signalling defects in apparently healthy children who developed invasive pneumococcal infection.

Aaron F Hirschfeld1, Julie A Bettinger, Rachel E Victor, Donald J Davidson, Andrew J Currie, J Mark Ansermino, David W Scheifele, Jordan S Orange, Stuart E Turvey.   

Abstract

Human primary immunodeficiencies affecting Toll-like receptor (TLR) signalling reveal a non-redundant role for TLR function in defense against pneumococcal infection. To determine the clinical relevance of TLR abnormalities, we studied a population predicted to be enriched for TLR defects-healthy children who had developed invasive pneumococcal infection in the absence of classic risk factors for infection. We describe the development and optimization of a peripheral blood TLR assay. By testing 38 healthy control neonates, children and adults we demonstrated that TLR function was stable over the first six decades of life. We tested 50 children with a history of invasive pneumococcal infection and although TLR defects were predicted to be over-represented in this population, we did not identify any TLR abnormalities. Although TLR signalling defects are associated with greatly enhanced susceptibility to invasive pneumococcal infection, our results suggest that routine clinical screening for TLR defects in healthy children who develop invasive pneumococcal infection is not justified.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17157070     DOI: 10.1016/j.clim.2006.10.012

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  12 in total

1.  Low early-life social class leaves a biological residue manifested by decreased glucocorticoid and increased proinflammatory signaling.

Authors:  Gregory E Miller; Edith Chen; Alexandra K Fok; Hope Walker; Alvin Lim; Erin F Nicholls; Steve Cole; Michael S Kobor
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-14       Impact factor: 11.205

2.  Factors underlying variable DNA methylation in a human community cohort.

Authors:  Lucia L Lam; Eldon Emberly; Hunter B Fraser; Sarah M Neumann; Edith Chen; Gregory E Miller; Michael S Kobor
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-08       Impact factor: 11.205

3.  Unbiased screening of marine sponge extracts for anti-inflammatory agents combined with chemical genomics identifies girolline as an inhibitor of protein synthesis.

Authors:  Shan-Yu Fung; Vladimir Sofiyev; Julia Schneiderman; Aaron F Hirschfeld; Rachel E Victor; Kate Woods; Jeff S Piotrowski; Raamesh Deshpande; Sheena C Li; Nicole J de Voogd; Chad L Myers; Charlie Boone; Raymond J Andersen; Stuart E Turvey
Journal:  ACS Chem Biol       Date:  2013-10-29       Impact factor: 5.100

4.  TLR4 Asp299Gly and Thr399Ile polymorphisms: no impact on human immune responsiveness to LPS or respiratory syncytial virus.

Authors:  Renée N Douville; Yuriy Lissitsyn; Aaron F Hirschfeld; Allan B Becker; Anita L Kozyrskyj; Joel Liem; Nathalie Bastien; Yan Li; Rachel E Victor; Mehtab Sekhon; Stuart E Turvey; Kent T HayGlass
Journal:  PLoS One       Date:  2010-08-10       Impact factor: 3.240

5.  Maternal warmth buffers the effects of low early-life socioeconomic status on pro-inflammatory signaling in adulthood.

Authors:  E Chen; G E Miller; M S Kobor; S W Cole
Journal:  Mol Psychiatry       Date:  2010-05-18       Impact factor: 15.992

6.  Acidification-dependent activation of CD1d-restricted natural killer T cells is intact in cystic fibrosis.

Authors:  Sarah E Rzemieniak; Aaron F Hirschfeld; Rachel E Victor; Mark A Chilvers; Dongjun Zheng; Peter van den Elzen; Stuart E Turvey
Journal:  Immunology       Date:  2010-01-19       Impact factor: 7.397

7.  Inflammasome-mediated IL-1β production in humans with cystic fibrosis.

Authors:  Anthony Tang; Ashish Sharma; Roger Jen; Aaron F Hirschfeld; Mark A Chilvers; Pascal M Lavoie; Stuart E Turvey
Journal:  PLoS One       Date:  2012-05-23       Impact factor: 3.240

8.  Rare variants in MYD88, IRAK4 and IKBKG and susceptibility to invasive pneumococcal disease: a population-based case-control study.

Authors:  Magda K Ellis; Katherine S Elliott; Anna Rautanen; Derrick W Crook; Adrian V S Hill; Stephen J Chapman
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

9.  Robust TLR4-induced gene expression patterns are not an accurate indicator of human immunity.

Authors:  Kelly L Brown; Reza Falsafi; Winnie Kum; Pamela Hamill; Jennifer L Gardy; Donald J Davidson; Stuart Turvey; Brett B Finlay; David P Speert; Robert E W Hancock
Journal:  J Transl Med       Date:  2010-01-27       Impact factor: 5.531

10.  The paracaspase MALT1 cleaves HOIL1 reducing linear ubiquitination by LUBAC to dampen lymphocyte NF-κB signalling.

Authors:  Theo Klein; Shan-Yu Fung; Florian Renner; Michael A Blank; Antoine Dufour; Sohyeong Kang; Madison Bolger-Munro; Joshua M Scurll; John J Priatel; Patrick Schweigler; Samu Melkko; Michael R Gold; Rosa I Viner; Catherine H Régnier; Stuart E Turvey; Christopher M Overall
Journal:  Nat Commun       Date:  2015-11-03       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.